Completed PHASE3 INTERVENTIONAL 3-arm NCT00671125

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

A Phase III, Randomized, Double-Blind Placebo-Controlled, PSG Plus Outpatient Study to Determine the Safety and Efficacy of TAK-375 in Adults With Chronic Insomnia

Sponsor: Takeda

Conditions Chronic Insomnia

Interventions Placebo Ramelteon

Updated 6 times since 2017 Last updated: Nov 8, 2012 Started: Jan 31, 2003 Primary completion: Sep 30, 2003 Completion: Sep 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Insomnia, this trial is completed. The trial is conducted by Takeda and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Takeda

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anaheim, United States , Atlanta, United States , Austin, United States , Birmingham, United States , Chevy Chase, United States , Chicago, United States , Cincinnati, United States , Crestview Hills, United States , Hot Springs, United States , Lafayette Hill, United States and 15 more locations